1. Nomogram to predict 1-year disease-specific survival of patients with pancreatic cancer who underwent resection following neoadjuvant treatment. Only preoperative clinical parameters, such as, age, symptom, image-based tumor size at diagnosis, preoperative serum CA 19-9 after neoadjuvant treatment, and planned surgery, were considered in developing a nomogram. CA, carbohydrate antigen; PP, pancreaticoduodenectomy; PPPD, pylorus-preserving pancreaticoduodenectomy; TP, total pancreatectomy; DPS, distal pancreatosplenectomy; DSS, disease-specific survival.
